| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.64 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.25 | 2e-07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 9e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |